<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05101538</url>
  </required_header>
  <id_info>
    <org_study_id>T113/2020</org_study_id>
    <nct_id>NCT05101538</nct_id>
  </id_info>
  <brief_title>Anorexia Nervosa and Its Effects on Brain Function, Body Metabolism and Their Interaction</brief_title>
  <acronym>AVAIN</acronym>
  <official_title>Anorexia Nervosa and it's Effects on Brain Function, Body Metabolism and Their Interaction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The neuromolecular and metabolic underpinnings of Anorexia Nervosa (AN) are studied using&#xD;
      multi-modal molecular (positron emission tomography with two different radioligands) and&#xD;
      functional (functional magnetic resonance imaging) neuroimaging in a prospective design.&#xD;
      Subjects with AN and normal weight adolescents will be studied with PET and MRI and followed&#xD;
      for five years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of sixty females (30 with AN, 30 healthy controls) are recruited into this&#xD;
      prospective study. The subjects will undergo physical examination, body tissue composition&#xD;
      measurement, functional and structural MRI of the brain and body, and positron emission&#xD;
      tomography (PET) with ligands [18F]-FDG, and [11C]carfentanil. Subjects' weight and physical&#xD;
      condition will be followed up for 5 years. The study will start in August 2020 and end in the&#xD;
      fall of 2028.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2027</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in brain reward system and metabolism in AN patients</measure>
    <time_frame>10 years</time_frame>
    <description>AN patients and controls are studied using fMRI and PET imaging and followed 10 years. Reward system function is measured using functional MRI and metabolism using 18F-fluorodeoxy glucose and PETCT imaging</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Predictive value of baseline body mass index (BMI), functional brain activation and metabolism in AN</measure>
    <time_frame>10 y</time_frame>
    <description>Results from baseline are combined with follow updata</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anorexia Nervosa</condition>
  <arm_group>
    <arm_group_label>patients and controls</arm_group_label>
    <description>AN patients and controls are recruited, studied using imaging and followed for 5 years</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Totallly 30 female subjects with anorexia nervosa are recuited from the Eating Disorder&#xD;
        Unit at the Turku University Hospital who meet the following criteria: i) modified DSM-IV&#xD;
        diagnosis of AN with or without amenorrhea; ii) AN onset before the age of 25 years; iii)&#xD;
        age between 18 and 32 3 years; iv) no lifetime history of binge eating. Their data are&#xD;
        compared with 30 age and sex-matched healthy controls&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for AN:&#xD;
&#xD;
          1. Female sex&#xD;
&#xD;
          2. Age 18-32 3 years&#xD;
&#xD;
          3. BMI &lt; 17.5 kg/m2&#xD;
&#xD;
          4. Currently fulfilling modified DSM-IV diagnosis of AN with or without amenorrhea, onset&#xD;
             age before 25 years&#xD;
&#xD;
          5. Diagnosed less than 2 years ago&#xD;
&#xD;
        For controls:&#xD;
&#xD;
          1. Female sex&#xD;
&#xD;
          2. Age 18-32 3 years&#xD;
&#xD;
          3. BMI 19 20-25 kg/m2&#xD;
&#xD;
          4. No lifetime history of obesity (BMI â‰¥&gt; 30) or eating disorders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Any chronic disease or medication that could affect glucose metabolism or&#xD;
             neurotransmission&#xD;
&#xD;
          2. History of psychiatric disorders (excl. AN for the corresponding study group)&#xD;
&#xD;
          3. Smoking of tobacco, taking of snuffs, or use of narcotics&#xD;
&#xD;
          4. Abusive use of alcohol&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>AN is more frequent in females, rare in males.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>32 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pirjo Nuutila, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku PET Centre, Turku University hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pirjo Nuutila, MD,PhD</last_name>
    <phone>0401626834</phone>
    <phone_ext>+358</phone_ext>
    <email>pirjo.nuutila@utu.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lauri Nummenmaa, PhD</last_name>
    <phone>0505747933</phone>
    <phone_ext>+358</phone_ext>
    <email>lauri.nummenmaa@utu.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Turku PET Centre</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanna Himanen, nurse</last_name>
      <phone>0469200200</phone>
      <phone_ext>358</phone_ext>
      <email>sanna.himanen@tyks.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 12, 2021</study_first_submitted>
  <study_first_submitted_qc>October 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Pirjo Nuutila</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Anorexia nervosa</keyword>
  <keyword>metabolism</keyword>
  <keyword>functional imaging</keyword>
  <keyword>PET</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

